Literature DB >> 33745592

Both muscle quantity and quality are predictors of waiting list mortality in patients with end-stage liver disease.

Daphne Bot1, Anneke Droop2, Claudia J Lucassen2, Mariëlle E van Veen2, Jeroen L A van Vugt3, Shirin Shahbazi Feshtali4, Eva Leistra5, Maarten E Tushuizen6, Bart van Hoek6.   

Abstract

BACKGROUND AND AIMS: Malnutrition is highly prevalent in patients with end-stage liver disease (ESLD) and associated with impaired clinical outcome. Previous studies focused on one component of body composition and not in combination with nutritional intake, while both are components of the nutritional status. We aimed to evaluate the most important risk factors regarding body composition (muscle mass, muscle quality and fat mass) and nutritional intake (energy and protein intake) for waiting list mortality in patients with ESLD awaiting liver transplantation (LTx).
METHODS: Consecutive patients with ESLD listed for LTx between 2007 and 2014 were investigated. Muscle mass quantity (Skeletal Muscle Mass Index, SMI), and muscle quality (Muscle Attenuation, MA), and various body fat compartments were measured on computed tomography using SliceOmatic. Nutritional intake (e.g. energy and protein intake) was assessed. Multivariable stepwise forward Cox regression analysis was used for statistical analysis.
RESULTS: 261 Patients (mean age 54 years, 74.7% male) were included. Low SMI and MA were found to be statistically significant predictors of an increased risk for waiting list mortality in patients with ESLD, with a HR of 2.580 (95%CI 1.055-6.308) and HR of 9.124 (95%CI 2.871-28.970), respectively. No association between percentage adipose tissue, and protein and energy intake with waiting list mortality was found in this study.
CONCLUSION: Both low muscle quantity and quality, and not nutritional intake, were independent risk factors for mortality in patients with ESLD.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Body composition; Liver cirrhosis; Liver transplantation; Malnutrition; Muscle; Sarcopenia

Year:  2021        PMID: 33745592     DOI: 10.1016/j.clnesp.2021.01.022

Source DB:  PubMed          Journal:  Clin Nutr ESPEN        ISSN: 2405-4577


  4 in total

1.  Should sarcopenia be an additional factor enough to affect liver transplant decision-making?

Authors:  Kang He; Qiang Xia
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

Review 2.  Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation.

Authors:  Amedeo Lonardo; Alessandro Mantovani; Salvatore Petta; Amedeo Carraro; Christopher D Byrne; Giovanni Targher
Journal:  Nat Rev Endocrinol       Date:  2022-07-15       Impact factor: 47.564

3.  Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis.

Authors:  Maryam Ebadi; Cynthia Tsien; Rahima A Bhanji; Abha R Dunichand-Hoedl; Elora Rider; Maryam Motamedrad; Vera C Mazurak; Vickie Baracos; Aldo J Montano-Loza
Journal:  Cells       Date:  2022-04-14       Impact factor: 7.666

Review 4.  Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions.

Authors:  Maryam Ebadi; Cynthia Tsien; Rahima A Bhanji; Abha R Dunichand-Hoedl; Elora Rider; Maryam Motamedrad; Vera C Mazurak; Vickie Baracos; Aldo J Montano-Loza
Journal:  Cells       Date:  2022-04-04       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.